Autres langues Danaher Corporation

Actions

DHR

US2358511028

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:03 10/07/2026 Varia. 5j. Varia. 1 janv.
199,05 USD +1,57% Graphique intraday de Danaher Corporation +0,57% -13,05%

Autres langues

11/07 US activist investors must disclose clients in filings, SEC says
03/07 Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?
29/06 Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
25/06 Germany's Merck to Buy Bio-Techne in $11 Billion Deal -- Update
25/06 Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne
22/06 Danaher Schedules Second Quarter 2026 Earnings Conference Call
22/06 Masimo Receives Fda 510(K) Clearance for Ai-Enabled Opioid-Induced Respiratory Depression Detection on Radius Vsm
22/06 Danaher Unit Receives FDA Clearance for Opioid-Induced Respiratory Depression Detection Feature
22/06 Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
10/06 Danaher Corporation completed the acquisition of Masimo Corporation from a group of shareholders.
10/06 Danaher Closes Acquisition of Masimo; Maintains Q2, 2026 Outlook
10/06 Danaher Completes Acquisition of Masimo Corporation
09/06 Sirius XM to Join S&P MidCap 400 Index
08/06 SiriusXM to Join S&P MidCap 400
03/06 Dh Masi Finance Inc. Enters into Note Purchase and Guaranty Agreement for Issuance of CHF 2,382,280,000 Senior Notes Guaranteed by Danaher Corporation
01/06 SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
01/06 SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
22/05 China's commerce ministry holds meeting with foreign pharmaceutical firms
22/05 Henry Schein Names William K. Daniel as Independent Chairman
21/05 Oxford Nanopore Technologies Names Chief Medical, Information Officers
15/05 Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says
15/05 Danaher Set for Growth Reacceleration Amid Strong Bioprocessing Trends, RBC Says
11/05 Aldevron co and Minaris renew lentiviral plasmid agreement to accelerate gene-modified cell therapy development
06/05 Danaher to Present at Bank of America Securities Healthcare Conference
05/05 Danaher Corp - declares quarterly cash dividend of $0.40 per share payable July 31, 2026
Aucun résultat pour cette recherche